Gamma Camera Market Size & Share [2033]

Gamma Camera Market Overview

The Gamma Camera Market size was valued at USD 674.55 million in 2024 and is expected to reach USD 835.08 million by 2033, growing at a CAGR of 2.4% from 2025 to 2033.

The Gamma Camera Market is witnessing significant advancements driven by technological innovations and the increasing prevalence of chronic diseases. In 2023, the global market was valued at approximately USD 2.8 billion, with projections indicating growth to USD 4.5 billion by 2032. Mobile gamma cameras, a subset of this market, are gaining traction due to their portability and efficiency in diagnostic imaging. In 2024, the mobile gamma cameras market was valued at USD 57.8 million, with expectations to reach USD 79.2 million by 2033.

Key Findings

Top Driver Reason: Rising demand for early and accurate diagnosis of diseases.

Top Country/Region: North America, holding over 35.0% market share in 2024.

Top Segment: Dual-Head Mobile Gamma Cameras, due to their enhanced imaging capabilities.

Gamma Camera Market Trends

The Gamma Camera Market is experiencing a dynamic evolution driven by several transformative trends across the medical imaging landscape. One of the most prominent trends is the integration of artificial intelligence (AI) into gamma camera systems. AI is increasingly being used to enhance image processing, automate diagnostic interpretation, and improve workflow efficiency. In 2024, over 27% of newly launched gamma camera models incorporated AI-based features, signaling a clear shift towards intelligent imaging. This technological enhancement significantly reduces the time taken for image reconstruction and improves diagnostic accuracy, especially in oncological and cardiovascular imaging applications. Another major trend is the rise of hybrid gamma camera systems, which combine gamma imaging with optical, CT, or MRI imaging. These hybrid modalities are particularly useful in areas like neuroimaging and breast cancer detection, where precise localization and multimodal insights are critical. More than 32% of high-end installations in 2023 included dual-modality gamma-optical systems, and this number is expected to rise as healthcare providers seek more comprehensive diagnostic tools. These hybrid systems also enable physicians to monitor therapy response with greater precision, fueling demand in both hospital and outpatient settings. The trend toward personalized medicine and targeted therapies is also fueling growth in the gamma camera market. Gamma cameras are being used extensively in nuclear medicine to visualize metabolic processes and receptor-ligand interactions at a molecular level. In 2024, approximately 48% of gamma camera applications in tertiary hospitals were focused on oncology and personalized radiopharmaceutical tracking. The adoption of gamma cameras in these applications is further encouraged by the growing availability of radiotracers and the emergence of radiogenomics. Additionally, the increased adoption of mobile gamma cameras is reshaping the landscape of diagnostic imaging. These compact, portable devices are especially popular in ambulatory surgical centers, rural healthcare setups, and emergency departments, where traditional imaging infrastructure is limited. In 2023, mobile gamma cameras accounted for 21.5% of all gamma camera unit sales, reflecting the shift toward point-of-care imaging. Manufacturers are focusing on designing lightweight and wireless models that can be easily transported between departments or remote facilities, thereby extending diagnostic capabilities beyond traditional hospital settings. Moreover, regulatory support and rising public-private investments in healthcare infrastructure are encouraging hospitals and imaging centers to upgrade or replace legacy systems. Several national healthcare systems in Europe and Asia have initiated programs offering financial subsidies for equipment modernization, which includes upgrading to next-generation gamma cameras. This not only drives the demand for new systems but also stimulates innovation in low-dose imaging and faster scanning techniques. In summary, the gamma camera market is being reshaped by advancements in AI, hybrid imaging technologies, personalized medicine applications, and mobile diagnostic systems. These trends are collectively enhancing diagnostic accuracy, expanding the use cases of gamma cameras, and driving increased adoption across both developed and emerging markets. As the demand for early disease detection and precision diagnostics continues to rise, these trends are expected to gain further momentum, solidifying the role of gamma cameras in the future of medical imaging.

Gamma Camera Market Dynamics

DRIVER

Rising demand for early and accurate diagnosis of diseases

The increasing prevalence of chronic diseases, such as cancer and cardiovascular conditions, necessitates early and precise diagnostic tools. Gamma cameras, particularly mobile variants, offer real-time imaging capabilities, enabling timely diagnosis and treatment. The global mobile gamma cameras market is projected to reach USD 79.2 million by 2033, reflecting the growing demand for advanced diagnostic imaging.

RESTRAINT

High costs associated with advanced gamma camera systems

The acquisition and maintenance costs of advanced gamma camera systems can be prohibitive, especially for smaller healthcare facilities. The integration of cutting-edge technologies, such as AI and hybrid imaging capabilities, further escalates costs, potentially limiting adoption in resource-constrained settings.

OPPORTUNITY

Expansion in emerging markets with growing healthcare infrastructure

Emerging economies, particularly in the Asia-Pacific region, are investing in healthcare infrastructure, creating opportunities for the adoption of gamma camera systems. The Asia-Pacific mobile gamma cameras market is set to experience significant growth, driven by increasing cancer and heart disease cases, along with developing healthcare infrastructure.

CHALLENGE

Regulatory hurdles and approval processes

The stringent regulatory requirements for medical imaging devices can delay the introduction of new gamma camera technologies. Navigating complex approval processes across different regions poses a challenge for manufacturers aiming to expand their market presence.

Gamma Camera Market Segmentation

The Gamma Camera Market is segmented by type and application:

By Type

Thyroid Scanning: Utilizes gamma cameras to assess thyroid gland function and detect abnormalities. The precision of gamma imaging aids in accurate diagnosis and treatment planning.
Molecular Breast Imaging: Employs gamma cameras for breast cancer detection, especially in patients with dense breast tissue. The technique enhances early detection rates and guides treatment decisions.
Kidney Scanning: Gamma cameras facilitate renal imaging to evaluate kidney function and detect obstructions or abnormalities. The non-invasive nature of the procedure makes it a preferred diagnostic tool.
Others: Includes applications in cardiac imaging, bone scanning, and neurological assessments, where gamma cameras provide functional imaging insights.

By Application

Large Hospitals: Major healthcare institutions utilize gamma cameras for a wide range of diagnostic procedures, benefiting from the systems' advanced imaging capabilities.
Small Clinics: Smaller healthcare facilities adopt mobile gamma cameras for their portability and cost-effectiveness, enabling on-site diagnostics without extensive infrastructure.

Gamma Camera Market Regional Outlook

The Gamma Camera Market demonstrates diverse growth patterns across major global regions, shaped by variations in healthcare infrastructure, disease prevalence, regulatory frameworks, and investment capacity. Each region contributes uniquely to the overall development of the global gamma camera market, with distinct drivers and emerging trends fueling demand for gamma imaging systems.

North America

North America holds the largest share in the gamma camera market, accounting for over 35.0% of the global market in 2024. This dominance is primarily attributed to the well-established healthcare infrastructure, high healthcare expenditure, and widespread adoption of advanced diagnostic imaging technologies. The United States leads the region, with more than 2,000 nuclear medicine departments equipped with gamma camera systems. The rise in chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has further propelled the demand for accurate, non-invasive diagnostic solutions. In 2023, over 450 new gamma camera units were installed in the U.S., many of which were mobile or hybrid models with AI integration. Additionally, the presence of key market players like GE Healthcare and Philips in the region promotes continual innovation and easy accessibility to next-generation imaging solutions. Government initiatives such as funding for cancer screening programs and the reimbursement support for nuclear medicine procedures are also contributing to the steady growth of the gamma camera market in North America.

Europe

Europe represents a mature and technologically progressive market for gamma cameras. In 2024, the region accounted for approximately 26.5% of global gamma camera sales, with leading contributions from Germany, the UK, France, and the Netherlands. The emphasis on early diagnosis, particularly in oncology and cardiology, has encouraged hospitals and imaging centers across Europe to invest in state-of-the-art imaging equipment. The European Association of Nuclear Medicine (EANM) actively promotes education and training in nuclear imaging, thereby increasing the pool of skilled professionals capable of utilizing gamma camera systems efficiently. The growing geriatric population, which is more susceptible to chronic diseases, further supports market growth. In 2023, more than 900,000 nuclear imaging procedures were conducted in Germany alone, with gamma cameras playing a vital role. The European Union’s investment in digital healthcare infrastructure and its regulations to promote safer and more efficient imaging equipment also foster a favorable environment for innovation and adoption of gamma cameras.

Asia-Pacific

The Asia-Pacific region is rapidly emerging as a high-potential market for gamma cameras, projected to witness strong growth over the next decade. Countries like China, India, Japan, and South Korea are leading the region in terms of demand, fueled by rising cancer rates, cardiovascular disease prevalence, and improvements in healthcare accessibility. In 2024, Asia-Pacific contributed approximately 22.8% to the global market volume, with China alone accounting for nearly 8.6%. The expansion of nuclear medicine departments across government and private hospitals in India and Southeast Asia is further increasing the uptake of gamma camera systems. Government initiatives in countries like India, such as the Ayushman Bharat health scheme, are improving access to advanced diagnostics in tier-2 and tier-3 cities. In Japan, technological innovation continues to drive demand, with a strong focus on hybrid imaging systems. By 2023, over 320 hospitals in Japan were equipped with multi-modality gamma imaging systems, showcasing the region's transition toward more advanced solutions. Asia-Pacific's large population base, coupled with increasing investments in healthcare modernization, makes it a strategic market for manufacturers aiming to expand their global footprint.

Middle East & Africa

The Middle East & Africa (MEA) region is gradually gaining traction in the gamma camera market, driven by improving healthcare infrastructure, rising awareness about early disease diagnosis, and increasing government initiatives. Although the market share remains smaller compared to other regions—accounting for around 7.5% of the global total in 2024—the region shows promising potential. Countries like Saudi Arabia, the UAE, and South Africa are investing heavily in advanced medical imaging technologies, including gamma cameras. In the Gulf Cooperation Council (GCC) region, public-private partnerships are boosting healthcare capabilities, leading to an increased number of nuclear medicine departments equipped with modern imaging systems. Saudi Arabia alone invested over USD 500 million in diagnostic imaging equipment procurement between 2022 and 2024. In sub-Saharan Africa, international aid programs and NGOs are supporting access to essential diagnostic tools, including mobile gamma cameras that can be used in rural or underserved areas. These developments, combined with a growing incidence of non-communicable diseases and rising healthcare awareness, are expected to support steady growth in the adoption of gamma cameras across the MEA region over the coming years.

List of Top Gamma Camera Market Companies

GE Healthcare
Philips Healthcare
Siemens Healthineers
Digirad Corporation
Mediso Ltd.
MIE Medical Imaging Electronics
DDD Diagnostic A/S
Dilon Technologies Inc.
Gamma Medica Inc.
Capintec Inc.
Beijing Hamamatsu Photon Techniques Inc.
Basda Medical Apparatus Co., Ltd.

Top Two Companies with Highest Market Shares

GE Healthcare: GE Healthcare is widely recognized as the leading company in the global gamma camera market, commanding a significant share owing to its advanced product portfolio, extensive distribution network, and commitment to innovation. As of 2024, GE Healthcare accounts for over 23% of the total gamma camera unit installations globally, making it the most dominant player in this segment. The company offers a range of gamma camera systems, including SPECT and SPECT/CT hybrids, tailored for nuclear cardiology, oncology, neurology, and general nuclear medicine imaging. Its flagship systems such as the Discovery NM/CT 870 CZT and Infinia Hawkeye 4 have set benchmarks for performance, resolution, and detector efficiency. GE’s innovations, especially in solid-state detectors (CZT technology), enable higher energy resolution and faster scanning times. The company has also integrated AI-enabled software for automated organ segmentation and dose reduction. In 2023 alone, GE launched three new gamma imaging models, including a portable version designed for use in intensive care units and outpatient settings. Additionally, GE's global service and support infrastructure, spanning more than 160 countries, enhances its competitive edge by ensuring reliable maintenance and system uptime.
Philips Healthcare: Philips Healthcare holds the second-largest share in the gamma camera market, with a strong presence in both developed and emerging markets. As of 2024, Philips is responsible for approximately 17% of total gamma camera deployments worldwide, particularly strong in Europe, Asia, and North America. The company’s nuclear medicine solutions are known for their user-centric design, advanced image processing algorithms, and integration with hospital IT systems. The Philips BrightView XCT gamma camera system, one of its top-selling products, combines SPECT with low-dose CT to deliver precise anatomical localization and functional imaging in a single scan. In 2023, Philips introduced enhancements to this system with faster reconstruction times and improved lesion detection accuracy. Another highlight is the SkyFlow AI software, which reduces noise and motion artifacts, enhancing image clarity without increasing patient dose. Philips also offers compact models targeted at outpatient clinics and smaller hospitals, contributing to the broader adoption of nuclear imaging technologies. Through strategic collaborations with academic institutions and healthcare providers, Philips continues to invest in research and clinical trials to validate its imaging solutions. Its strong focus on sustainability, digital transformation, and personalized healthcare aligns well with the evolving needs of the gamma camera market, helping maintain its competitive position across diverse geographies.

Investment Analysis and Opportunities

Investments in the Gamma Camera Market are driven by the need for advanced diagnostic imaging solutions. The integration of AI and machine learning in gamma cameras enhances diagnostic accuracy and efficiency, attracting investments from healthcare providers and technology firms. The development of hybrid imaging systems, combining gamma imaging with other modalities, presents lucrative opportunities for market growth. These systems offer comprehensive diagnostic insights, appealing to healthcare facilities aiming to improve patient outcomes. Emerging markets, particularly in the Asia-Pacific region, present significant investment opportunities due to expanding healthcare infrastructure and increasing demand for advanced diagnostic tools. Governments and private entities are investing in healthcare modernization, creating a conducive environment for gamma camera adoption. Collaborations between medical device manufacturers and research institutions are fostering innovation in gamma camera technologies. These partnerships aim to develop cost-effective, high-performance imaging solutions, addressing the needs of diverse healthcare settings.

New Product Development

Innovation in the Gamma Camera Market focuses on enhancing imaging capabilities, portability, and integration with digital technologies. Manufacturers are developing compact, mobile gamma cameras equipped with advanced detectors and AI-driven software for improved diagnostic accuracy. The introduction of hybrid gamma-optical cameras enables multi-modality imaging, providing detailed anatomical and functional information in a single scan. These systems are particularly beneficial in oncology and surgical applications, where precise imaging is crucial. Advancements in detector materials, such as Cadmium Zinc Telluride (CZT), improve energy resolution and sensitivity, enhancing image quality. The adoption of solid-state detectors contributes to the miniaturization of gamma camera systems, facilitating their use in various clinical settings. Integration with digital health platforms allows for seamless data sharing and remote diagnostics, aligning with the growing trend of telemedicine. These developments support the expansion of gamma camera applications beyond traditional hospital environments.

Five Recent Developments

GE Healthcare launched a new mobile gamma camera system with enhanced imaging capabilities, aiming to improve diagnostic accuracy in oncology applications.
Philips Healthcare introduced an AI-powered gamma camera platform, integrating machine learning algorithms for real-time image analysis and decision support.
Siemens Healthineers developed a hybrid gamma-optical imaging system, combining functional and anatomical imaging for comprehensive diagnostics.
Digirad Corporation expanded its product portfolio with a portable gamma camera designed for point-of-care diagnostics in emergency and outpatient settings.
Mediso Ltd. collaborated with research institutions to develop a next-generation gamma camera system featuring advanced detector technology and improved image resolution.

Report Coverage of Gamma Camera Market

This report provides an in-depth analysis of the Gamma Camera Market, covering market dynamics, segmentation, regional outlook, and competitive landscape. It examines the factors driving market growth, including technological advancements, increasing prevalence of chronic diseases, and the shift towards personalized medicine. The report explores market segmentation by type and application, highlighting the diverse uses of gamma cameras in medical diagnostics. It assesses regional market performance, identifying key growth areas and investment opportunities. Profiles of leading market players offer insights into their product offerings, strategic initiatives, and market positioning. The report also discusses recent developments and innovations shaping the future of the Gamma Camera Market. By providing comprehensive coverage, this report serves as a valuable resource for stakeholders seeking to understand market trends, identify growth opportunities, and make informed business decisions in the Gamma Camera Market.